Bellevue Group AG Cash Flow Conversion Efficiency
Bellevue Group AG cash flow conversion efficiency. Based on the latest financial reports, Bellevue Group AG (BBN) has a cash flow conversion efficiency ratio of 0.150x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF16.84 Million ≈ $21.29 Million USD) by net assets (CHF112.53 Million ≈ $142.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Bellevue Group AG (2002–2024)
Cash flow conversion efficiency of Bellevue Group AG from 2002 to 2024. This chart illustrates how Bellevue Group AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BBN share price today for real-time trading data and today's change.
Bellevue Group AG Cash Flow Conversion Ratio Explained
Bellevue Group AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Bellevue Group AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bellevue Group AG ranked by their cash flow conversion efficiency. Also see BBN market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DAE HWA Pharmaceutical Co. Ltd
KQ:067080
|
-0.020x |
|
Global Fashion Group S.A
F:GFG
|
-0.222x |
|
MPH Health Care AG
F:93M1
|
-0.003x |
|
Mitrabara Adiperdana PT
JK:MBAP
|
-0.004x |
|
Titan Minerals Ltd
AU:TTM
|
-0.013x |
|
Min Aik Technology Co Ltd
TW:3060
|
-0.028x |
|
Biotrend Cevre ve Enerji Yatirimlari AS
IS:BIOEN
|
0.021x |
|
TK Chemical Corporation
KQ:104480
|
0.005x |
Annual Cash Flow Conversion Efficiency for Bellevue Group AG (2002–2024)
The table below shows the annual cash flow conversion efficiency of Bellevue Group AG from 2002 to 2024. Review BBN free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CHF118.52 Million ≈ $149.84 Million |
CHF9.40 Million ≈ $11.89 Million |
0.079x | +9.33% |
| 2023-12-31 | CHF122.47 Million ≈ $154.83 Million |
CHF8.89 Million ≈ $11.23 Million |
0.073x | -65.51% |
| 2022-12-31 | CHF133.89 Million ≈ $169.27 Million |
CHF28.17 Million ≈ $35.61 Million |
0.210x | -55.77% |
| 2021-12-31 | CHF146.59 Million ≈ $185.33 Million |
CHF69.73 Million ≈ $88.16 Million |
0.476x | -46.92% |
| 2020-12-31 | CHF165.82 Million ≈ $209.64 Million |
CHF148.60 Million ≈ $187.87 Million |
0.896x | +343.58% |
| 2019-12-31 | CHF198.35 Million ≈ $250.77 Million |
CHF-72.98 Million ≈ $-92.27 Million |
-0.368x | -500.65% |
| 2018-12-31 | CHF442.17 Million ≈ $559.02 Million |
CHF40.61 Million ≈ $51.34 Million |
0.092x | +65.66% |
| 2017-12-31 | CHF425.01 Million ≈ $537.33 Million |
CHF23.56 Million ≈ $29.79 Million |
0.055x | -26.43% |
| 2016-12-31 | CHF440.36 Million ≈ $556.73 Million |
CHF33.18 Million ≈ $41.95 Million |
0.075x | +126.22% |
| 2015-12-31 | CHF135.96 Million ≈ $171.89 Million |
CHF-39.07 Million ≈ $-49.39 Million |
-0.287x | -928.69% |
| 2014-12-31 | CHF402.44 Million ≈ $508.80 Million |
CHF-11.24 Million ≈ $-14.21 Million |
-0.028x | +94.47% |
| 2013-12-31 | CHF149.45 Million ≈ $188.95 Million |
CHF-75.51 Million ≈ $-95.47 Million |
-0.505x | -176.98% |
| 2012-12-31 | CHF161.21 Million ≈ $203.82 Million |
CHF105.81 Million ≈ $133.77 Million |
0.656x | +1900.24% |
| 2011-12-31 | CHF190.63 Million ≈ $241.00 Million |
CHF6.25 Million ≈ $7.91 Million |
0.033x | +105.45% |
| 2010-12-31 | CHF294.84 Million ≈ $372.76 Million |
CHF-177.59 Million ≈ $-224.53 Million |
-0.602x | -440.16% |
| 2009-12-31 | CHF332.73 Million ≈ $420.66 Million |
CHF58.92 Million ≈ $74.49 Million |
0.177x | -61.43% |
| 2008-12-31 | CHF454.64 Million ≈ $574.79 Million |
CHF208.73 Million ≈ $263.89 Million |
0.459x | +8.52% |
| 2007-12-31 | CHF478.14 Million ≈ $604.50 Million |
CHF202.29 Million ≈ $255.75 Million |
0.423x | +275.92% |
| 2003-12-31 | CHF301.42 Million ≈ $381.08 Million |
CHF-72.49 Million ≈ $-91.65 Million |
-0.240x | -125.99% |
| 2002-12-31 | CHF267.98 Million ≈ $338.80 Million |
CHF248.01 Million ≈ $313.55 Million |
0.925x | -- |
About Bellevue Group AG
Bellevue Group AG provides asset management services in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid caps, and private equity strategies; and multi asset,… Read more